Muscle and tissue radiodensity matter: Automated CT-based body composition analysis predicts survival in hepatocellular carcinoma patients undergoing degradable starch microspheres transarterial chemoembolization (DSM-TACE)
Therapeutic Advances in Medical Oncology · 2026-11 · 18
DOI: 10.1177/17588359261501121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 06.11.2026. Verfasst von Leonie S. Jochheim und 10 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE) has emerged as an increasingly important and effective treatment for hepatocellular carcinoma (HCC); however, the impact of body composition on clinical outcomes remains unknown.
Objectives
This study aimed to assess the prognostic significance of pretreatment, fully automated 3D-volumetric computed tomography (CT)-based body composition analysis (BCA) in patients with HCC undergoing DSM-TACE.
Design
Retrospective single-center study.
Methods
A total of 137 patients were treated with repetitive DSM-TACE. BCA quantified the volumes and radiodensities of the skeletal muscle (SM), visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and bone (B) using baseline abdominal CT scans. The maximally selected log-rank test was applied for the cutoff selection. Survival outcomes were analyzed using Kaplan-Meier curves and uni- and multivariate Cox proportional hazards models with hazard ratios (HR).
Results
The median overall survival (OS) of the cohort was 16.5 months. Multivariate analysis identified three BCA parameters as independent predictors of improved survival: a high SM/B ratio (HR: 0.44; p = 0.008), high SM radiodensity (HR: 0.26; p = 0.004), and low VAT radiodensity (HR: 0.20; p = 0.004). A cumulative risk score based on these independent factors (1 point per favorable factor) allowed for distinct survival stratification ( p < 0.0001), with median OS ranging from 34.4 months in the low-risk group (score 3) to 17.7, 10.1, and 2.8 months for scores of two to zero points (pairwise comparison p ≤ 0.016). Survival stratification remained statistically significant in both the Barcelona Clinic Liver Cancer (BCLC) stage B and C subgroups.
Conclusion
Fully automated CT-based quantification of body composition is a valuable tool for assessing survival in patients with HCC treated with DSM-TACE. The integration of the SM/B ratio and tissue radiodensities enable can improve personalized survival stratification within the BCLC B and C subgroups, warranting further validation and clinical integration evaluation.
Zitieren
APA
Jochheim, L. S., Steinberg, H. L., Zeller, A. C., Best, J., Theysohn, J. M., Rahe, G., Schaarschmidt, B. M., Schramm, C., Haubold, J., Schmidt, H., & Ludwig, J. M. (2026). Muscle and tissue radiodensity matter: Automated CT-based body composition analysis predicts survival in hepatocellular carcinoma patients undergoing degradable starch microspheres transarterial chemoembolization (DSM-TACE). Therapeutic Advances in Medical Oncology, 18. https://doi.org/10.1177/17588359261501121
Vancouver
Jochheim LS, Steinberg HL, Zeller AC, Best J, Theysohn JM, Rahe G, et al. Muscle and tissue radiodensity matter: Automated CT-based body composition analysis predicts survival in hepatocellular carcinoma patients undergoing degradable starch microspheres transarterial chemoembolization (DSM-TACE). Therapeutic Advances in Medical Oncology. 2026;18. doi:10.1177/17588359261501121
BibTeX
@article{Jochheim2026,
author = {Jochheim, Leonie S. and Steinberg, Hannah L. and Zeller, Amos C. and Best, Jan and Theysohn, Jens M. and Rahe, Gilbert and Schaarschmidt, Benedikt M. and Schramm, Christoph and Haubold, Johannes and Schmidt, Hartmut and Ludwig, Johannes M.},
title = {Muscle and tissue radiodensity matter: Automated CT-based body composition analysis predicts survival in hepatocellular carcinoma patients undergoing degradable starch microspheres transarterial chemoembolization (DSM-TACE)},
journal = {Therapeutic Advances in Medical Oncology},
year = {2026},
volume = {18},
doi = {10.1177/17588359261501121}
}
EUVIMED